Skip to main content

Peer Review reports

From: Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer

Original Submission
2 Mar 2022 Submitted Original manuscript
31 Mar 2022 Reviewed Reviewer Report
9 Apr 2022 Reviewed Reviewer Report - Ashley M Hopkins
20 Apr 2022 Reviewed Reviewer Report
23 May 2022 Author responded Author comments - Juan Zhou
Resubmission - Version 2
23 May 2022 Submitted Manuscript version 2
23 May 2022 Reviewed Reviewer Report
25 May 2022 Reviewed Reviewer Report - Ashley M Hopkins
2 Jun 2022 Reviewed Reviewer Report
14 Jun 2022 Author responded Author comments - Juan Zhou
Resubmission - Version 3
14 Jun 2022 Submitted Manuscript version 3
Publishing
17 Jun 2022 Editorially accepted
29 Jul 2022 Article published 10.1186/s12916-022-02444-8

You can find further information about peer review here.

Back to article page